A Study of BMS-813160 in Combination With Chemotherapy or Nivolumab in Participants With Advanced Solid Tumors
Clinical trial NCT03184870 · COMPLETED
Trial details
- NCT number
- NCT03184870
- Sponsor
- Bristol-Myers Squibb
- Status
- COMPLETED
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2017-08-08
- Primary completion
- 2023-04-06
- Enrollment
- 332
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.